The ATR kinase inhibitor AZD6738 was observed to attenuate radiation-induced CD8+ T cell depletion and enhance CD8+ T cell activity in mouse models of KRAS-mutated cancer in combination with conformal RT. This evidence concerns the gene CD8A and cancer.